Cite
HARVARD Citation
Ito, K. et al. (2021). Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study. European journal of cancer. pp. 183-193. [Online].